Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress
Los Angeles, California--(Newsfile Corp. - June 18, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Quantum BioPharma Ltd.'s (NASDAQ: QNTM) continued progress across its innovative pipeline of treatments for brain disorders and alcohol health.A link to the report is available here: https://files.constantcontact.com/1683279a601/2551ab59-a629-4103-8f4b-fa3fbf21f4a5.pdf?rdr=trueClinical Development MilestonesQuantum BioPharma has achieved significant progress with its FSD202 program, receiving human ethics review committee (HREC) approval for
2025-06-18 9:19 AM EDT
Singular Research Reports on Innovative Solutions & Support's Q2 2025 Results
Los Angeles, California--(Newsfile Corp. - May 27, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Innovative Solutions & Support, Inc.'s (NASDAQ: ISSC) second quarter fiscal year 2025 financial results.A link to the report is available here: https://files.constantcontact.com/1683279a601/64403f22-951b-4c9c-b9c8-e193137d5314.pdf?rdr=trueKey Financial Highlights:Q2 revenue more than doubled year-over-year to $21.9 millionNet income surged 300% to $5.3 millionAdjusted EPS for Q2 was $0.30, compared to $0.07 in Q2 2024Adjusted EB
2025-05-27 9:00 AM EDT
Singular Research Reports on Oportun Financials' Q1 2025 Results
Los Angeles, California--(Newsfile Corp. - May 21, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Oportun Financial Corporation's (NASDAQ: OPRT) first quarter 2025 financial results.A link to the report is available here: https://files.constantcontact.com/1683279a601/2d706010-a709-4c43-8de7-4b7083b5cd54.pdf?rdr=trueKey Financial Highlights:Q1 earnings exceeded expectations as the Company delivered its second consecutive quarter of GAAP profitabilityTotal revenue for Q1 was $235.9 millionAdjusted EPS for Q1 was $0.40, compared to $0.09 in Q1 202
2025-05-21 3:31 PM EDT
Singular Research Highlights Favorable Assay Results and Strategic Expansions by Myriad Uranium
Los Angeles, California--(Newsfile Corp. - April 10, 2025) - Singular Research has released an updated report on Myriad Uranium Ltd. (OTCQB: MYRUF), highlighting the Company's recent advancements, including favorable chemical assay results and strategic project expansions.Myriad Uranium's latest chemical assays confirm that U₃O₈ grades are 20% higher than previously reported gamma grades, reinforcing the project's resource potential. Additionally, the Company announced a major expansion of its Copper Mountain Project Area and secured an option to acquire 100% of the Red...
2025-04-10 1:49 PM EDT
Singular Research Reports on Oportun Financial's Q4 and Full Year 2024 Results
Los Angeles, California--(Newsfile Corp. - February 14, 2025) - Singular Research, a leading provider of independent research on small-cap companies, today released its analysis of Oportun Financial Corporation's (NASDAQ: OPRT) fourth quarter and full year 2024 financial results.A link to the report is available here: https://files.constantcontact.com/1683279a601/31fdf5bd-d506-4885-8225-9021aab520d2.pdf?rdr=trueKey Financial Highlights:Q4 earnings exceeded expectations as the Company returned to GAAP profitabilityTotal revenue for Q4 was $251 millionAdjusted EPS for Q4 was $0.49, compared to $(0.21) in Q4 2023Full year 2024 adjusted EPS...
2025-02-14 5:02 PM EST
Singular Research Highlights Oportun Financial Corp. in a Recent Report
Los Angeles, California--(Newsfile Corp. - December 18, 2024) - Singular Research highlights Oportun Financial Corp (NASDAQ: OPRT), a leading financial services provider focused on credit solutions for underserved markets. Following an exceptional Q3 2024 performance, Oportun demonstrated significant financial improvements and operational efficiencies.Highlights from the Q3 2024 UpdateSolid Financial Results: Oportun achieved $31 million in adjusted EBITDA, up 117% year-over-year, driven by lower net charge-offs and cost reductions. Adjusted net income reached $0.9 million or $0.02 per share, marking a...
2024-12-18 10:25 AM EST
Singular Research Announces the 20th Annual Best of the Uncovereds Conference
San Francisco, California--(Newsfile Corp. - December 11, 2024) - Singular Research proudly invites investors, analysts, and small-cap enthusiasts to the 20th Annual Best of the Uncovereds Conference on Thursday, December 12, 2024. The event will be held at the AMA Executive Conference Center, located at 55 Fourth Street, 2nd Level inside the Marriott Marquis, in San Francisco.This year's confe
2024-12-11 2:00 PM EST